Analysis of reactivation of hepatitis B virus in the treatment of B cell non-Hodgkin's lymphoma in Hokkaido

被引：36

作者：

Tsutsumi, Yutaka ^{[1
]}

Shigematsu, Akio ^{[2
]}

Hashino, Satoshi ^{[3
]}

Tanaka, Junji ^{[2
]}

Chiba, Kouji ^{[4
]}

Masauzi, Nobuo ^{[1
]}

Kobayashi, Hajime ^{[8
]}

Kurosawa, Mitsutoshi ^{[5
]}

Iwasaki, Hiroshi ^{[6
]}

Morioka, Masanobu ^{[7
]}

Asaka, Masahiro ^{[3
]}

Imamura, Masahiro ^{[2
]}

机构：

[1] Hakodate Municipal Hosp, Dept Internal Med, Hakodate, Hokkaido 0418680, Japan

[2] Hokkaido Univ, Grad Sch Med, Dept Hematol & Oncol, Sapporo, Hokkaido, Japan

[3] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol, Sapporo, Hokkaido, Japan

[4] Asahikawa Municipal Hosp, Dept Internal Med, Asahikawa, Hokkaido, Japan

[5] Natl Canc Ctr, Dept Hematol, Sapporo, Hokkaido, Japan

[6] Sapporo Kosei Hosp, Dept Internal Med, Sapporo, Hokkaido, Japan

[7] Aiiku Hosp, Dept Internal Med, Sapporo, Hokkaido, Japan

[8] Obihiro Kosei Hosp, Dept Internal Med, Obihiro, Hokkaido, Japan

来源：

ANNALS OF HEMATOLOGY | 2009年 / 88卷 / 04期

关键词：

RITUXIMAB THERAPY; FOLLICULAR LYMPHOMA; PATIENT; CHEMOTHERAPY; INFECTION;

D O I：

10.1007/s00277-008-0585-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：375 / 377

页数：3

共 13 条

[1]

Bermúdez A, 2000, HAEMATOLOGICA, V85, P894

[2] Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy [J].

Czuczman, MS ;

Grillo-López, AJ ;

White, CA ;

Saleh, M ;

Gordon, L ;

LoBuglio, AF ;

Jonas, C ;

Klippenstein, D ;

Dallaire, B ;

Varns, C .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :268-276

[3] Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. [J].

Dervite, I ;

Hober, D ;

Morel, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (01) :68-69

[4] Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab [J].

Goldberg, SL ;

Pecora, AL ;

Alter, RS ;

Kroll, MS ;

Rowley, SD ;

Waintraub, SE ;

Imrit, K ;

Preti, RA .

BLOOD, 2002, 99 (04) :1486-1488

[5] Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study [J].

Igarashi, T ;

Kobayashi, Y ;

Ogura, M ;

Kinoshita, T ;

Ohtsu, T ;

Sasaki, Y ;

Morishima, Y ;

Murate, T ;

Kasai, M ;

Uike, N ;

Taniwaki, M ;

Kano, Y ;

Ohnishi, K ;

Matsuno, Y ;

Nakamura, S ;

Mori, S ;

Ohashi, Y ;

Tobinai, K .

ANNALS OF ONCOLOGY, 2002, 13 (06) :928-943

[6] Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report [J].

Ng, HJ ;

Lim, LC .

ANNALS OF HEMATOLOGY, 2001, 80 (09) :549-552

[7]

PEREAU G, 2006, BRIT J DERMATOL, V155, P1053, DOI DOI 10.1111/J.1365-2133.2006.07451.X

[8] Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab [J].

Sharma, VR ;

Fleming, DR ;

Slone, SP .

BLOOD, 2000, 96 (03) :1184-1186

[9] Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder. [J].

Suzan, F ;

Ammor, M ;

Ribrag, V .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (13) :1000-1000

[10] Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma [J].

Tsutsumi, Y ;

Tanaka, J ;

Kawamura, T ;

Miura, T ;

Kanamori, H ;

Obara, S ;

Asaka, M ;

Imamura, M ;

Masauzi, N .

ANNALS OF HEMATOLOGY, 2004, 83 (01) :58-60

← 1 2 →